Surgical Innovations Group PLC - Leeds, England-based surgical and medical instrument manufacturer - Says the strong trading seen in the final quarter of 2021 has continued into the first half of 2022. Revenue for the six months to June 30 is expected 22% above the same period last year. Company is confident in delivering full-year results in line with expectations as a result of strong UK market demand, above pre-pandemic levels.

Company notes, however, its regulatory pathway is ‘challenging’ and its labour market has become ‘increasingly’ challenging due to inflationary pressures. This has results in extended sales order lead times and impacted manufacturing productivity, it explains.

Current stock price: 1.88 pence, up 7.4% in London on Monday

12-month change: down 42%

Copyright 2022 Alliance News Limited. All Rights Reserved.